Trump announces reforms to accelerate access to psychedelic drug treatments
InternationalTrump announces reforms to accelerate access to psychedelic drug treatmentsBy Reuters -Apr 18, 2026WASHINGTON: US President Donald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs. Trump planned to sign an executive order that would direct the U.S. Food and Drug Administration to expedite review of drugs such as ibogaine, a drug that U.S. military veteran groups have said can help treat post-traumatic stress disorder. At an event in the Oval Office, U.S. federal officials said that the reforms would pave the way for the drugs, which can cause hallucinations and are largely illegal, to be reclassified after successful clinical trials. Trump also said the U.S. would dedicate $50 million to federal research into ibogaine.المصدر: ARY News EN | Source: ARY News EN
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة ARY News EN. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by ARY News EN. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
